Resolving inflammatory bowel disease risk variants to genes and cell types
Laura Fachal, Rui Zhang, Kyle Gettler, Talin Haritunians, Isabelle Cleynen, Christine R. Stevens, Qian Zhang, Christopher Tastad, Catalina Medici, Ron Do, Maria Teresa Abreu, Jean–Paul Achkar, Tariq Ahmad, Klaartje Bel Kok, Charles Bernstein, , Judy H. Cho
This study identifies 619 IBD risk signals, resolves 81 high-confidence variants, and prioritizes 664 candidate effector genes using GWAS, eQTL, and exome sequencing.
medRxiv · May 23, 2026 · PreprintGenetic & Genomic Medicine